Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents
A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI
Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial
Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable Polymer Sirolimus-Eluting Stent: Randomized Substudy of the I-LOVE-IT 2 Trial
Dual Antiplatelet Therapy Duration: Reconciling the Inconsistencies
Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome: The TICO Randomized Clinical Trial
Ticagrelor with or without Aspirin in High-Risk Patients after PCI
Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel: The ABCD-GENE Score